State of the art of sentinel lymph node biopsy in vulvar carcinoma

Women's Health

Volumn 5, Issue 5, 2009, Pages 555-563

  McGee, Jacob ^b   Covens, Allan ^a,b  

^a DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Accuracy; Cellulitis; Combined modality therapy; Female; Gynecologic surgical procedure method; Humans; Lymph node excision; Lymphedema; Negative predictive value; Pathology; Sentinel lymph node biopsy method; Treatment outcome; Vulvar neoplasm surgery; Wound breakdown

Indexed keywords

DYE;

BACTERIAL INFECTION; CANCER RECURRENCE; CANCER STAGING; DIAGNOSTIC ACCURACY; FALSE NEGATIVE RESULT; FEMALE; FROZEN SECTION; HUMAN; INGUINAL LYMPH NODE; INTERMETHOD COMPARISON; ISOTOPE LABELING; LENGTH OF STAY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; LYMPHEDEMA; MORBIDITY; REOPERATION; REVIEW; RISK REDUCTION; SENSORY DYSFUNCTION; SENTINEL LYMPH NODE BIOPSY; SURGICAL TECHNIQUE; VULVA CARCINOMA; VULVECTOMY; GYNECOLOGIC SURGERY; LYMPHATIC SYSTEM DISEASE; PATHOLOGY; PROCEDURES; TRENDS; VULVA; VULVAR NEOPLASMS;

FEMALE; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; LYMPHATIC DISEASES; NEOPLASM STAGING; SENTINEL LYMPH NODE BIOPSY; VULVA; VULVAR NEOPLASMS;

EID: 69849105155     PISSN: 17455057     EISSN: 17455065     Source Type: Journal    
DOI: 10.2217/whe.09.37     Document Type: Review

References (54)

1. Jemal A, Tiwari RC, Murray T et al.: Cancer statistics, 2004. CA Cancer J. Clin. 54(1), 8-29 (2004).
2. DiSaia P, Creasman W: Invasive cancer of the vulva. In: Clinical Gynecologic Oncology. Elsevier, Amsterdam, The Netherlands (2007).
3. DiSaia P, Creasman W, Rich W: An alternative approach to early cancer of the vulva. Am. J. Obstet. Gynecol. 113, 825-831 (1979).
4. Andersen BL, Hacker NF: Psychosexual adjustment after vulvar surgery. Obstet. Gynecol. 62(4), 457-462 (1983).
5. Hacker NF, Berek JS, Lagasse LD et al.: Management of regional lymph nodes and their prognostic influence in vulvar cancer. Obstet. Gynecol. 61(4), 408-412 (1983).
6. Selman TJ, Luesley DM, Acheson N et al.: A systematic review of the accuracy of diagnostic tests for inguinal lymph node status in vulvar cancer. Gynecol. Oncol. 99(1), 206-214 (2005).
7. de Hullu JA, van der Zee AG: Surgery and radiotherapy in vulvar cancer. Crit. Rev. Oncol. Hematol. 60(1), 38-58 (2006).
8. Saito T, Kato K: Management of lymph nodes in the treatment of vulvar cancer. Int. J. Clin. Oncol. 12(3), 187-191 (2007).
9. Iversen T, Aas M: Lymph drainage from the vulva. Gynecol. Oncol. 16(2), 179-189 (1983).
10. Pecorelli S, Ngan HYS, Hacker NF: Cancer of the vulva. In: Staging Classification and Clinical Practice Guidelines for Gynecological Cancers. A Collaboration Between FIGO and IGCS (Third Edition). 6-36 (2006).
11. Stehman FB, Bundy BN, Dvoretsky PM et al.: Early stage I carcinoma of the vulva treated with ipsilateral superficial inguinal lymphadenectomy and modified radical hemivulvectomy: a prospective study of the gynecologic oncology group. Obstet. Gynecol. 79(4), 490-497 (1992).
12. de Hullu JA, van der Avoort IA, Oonk MH et al.: Management of vulvar cancers. Eur. J. Surg. Oncol. 32(8), 825-831 (2006).
13. Ansink A, van der Velden J: Surgical interventions for early squamous cell carcinoma of the vulva. Cochrane Database Syst. Rev. (2), 002036 (2000).
14. Podratz KC, Symmonds RE, Taylor WF: Carcinoma of the vulva: Analysis of treatment failures. Am. J. Obstet. Gynecol. 143(3), 340-351 (1982).
15. Gaarenstroom KN, Kenter GG, Trimbos JB et al.: Postoperative complications after vulvectomy and inguinofemoral lymphadenectomy using separate groin incisions. Int. J. Gynecol. Cancer 13(4), 522-527 (2003).
16. Gould N, Kamelle S, Tillmanns T et al.: Predictors of complications after inguinal lymphadenectomy. Gynecol. Oncol. 82(2), 329-332 (2001).
17. Rouzier R, Haddad B, Dubernard G et al.: Inguinofemoral dissection for carcinoma of the vulva: effect of modifications of extent and technique on morbidity and survival. J. Am. Coll. Surg. 196(3), 442-450 (2003).
18. Carlson JW, Kauderer J, Walker JL et al.: A randomized Phase III trial of VH fibrin sealant to reduce lymphedema after inguinal lymph node dissection: a gynecologic oncology group study. Gynecol. Oncol. 110(1), 76-82 (2008).
19. Weijmar Schultz WC, van de Wiel HB, Bouma J et al.: Psychosexual functioning after the treatment of cancer of the vulva. A longitudinal study. Cancer 66(2), 402-407 (1990).
20. Barton DP: The prevention and management of treatment related morbidity in vulval cancer. Best Pract. Res. Clin. Obstet. Gynaecol. 17(4), 683-701 (2003).
21. Pereira de Godoy JM, Braile DM, de Fatima Godoy M et al.: Quality of life and peripheral lymphedema. Lymphology 35(2), 72-75 (2002).
22. Mansel RE, Fallowfield L, Kissin M et al.: Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial. J. Natl Cancer Inst. 98(9), 599-609 (2006).
23. van der Zee AG, Oonk MH, de Hullu JA et al.: Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J. Clin. Oncol. 26(6), 884-889 (2008).
24. Barton DP, Berman C, Cavanagh D et al.: Lymphoscintigraphy in vulvar cancer: a pilot study. Gynecol. Oncol. 46(3), 341-344 (1992).
25. Hauspy J, Beiner M, Harley I et al.: Sentinel lymph node in vulvar cancer. Cancer 110(5), 1015-1023 (2007).
26. Levenback CF: How safe is sentinel lymph node biopsy in patients with vulvar cancer? J. Clin. Oncol. 26(6), 828-829 (2008).
27. Classe JM, Curtet C, Campion L et al.: Learning curve for the detection of axillary sentinel lymph node in breast cancer. Eur. J. Surg. Oncol. 29(5), 426-433 (2003).
28. Morton DL, Thompson JF, Essner R et al.: Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter selective lymphadenectomy trial group. Ann. Surg. 230(4), 453-463 (1999).
29. Levenback C, Burke TW, Gershenson DM et al.: Intraoperative lymphatic mapping for vulvar cancer. Obstet. Gynecol. 84(2), 163-167 (1994).
30. Levenback C, Coleman RL, Burke TW et al.: Intraoperative lymphatic mapping and sentinel node identification with blue dye in patients with vulvar cancer. Gynecol. Oncol. 83(2), 276-281 (2001).
31. Dhar KK, Woolas RP: Lymphatic mapping and sentinel node biopsy in early vulvar cancer. BJOG 112(6), 696-702 (2005).
32. Nyberg RH, Iivonen M, Parkkinen J et al.: Sentinel node and vulvar cancer: a series of 47 patients. Acta Obstet. Gynecol. Scand. 86(5), 615-619 (2007).
33. de Hullu JA, Hollema H, Piers DA et al.: Sentinel lymph node procedure is highly accurate in squamous cell carcinoma of the vulva. J. Clin. Oncol. 18(15), 2811-2816 (2000).
34. Decesare SL, Fiorica JV, Roberts WS et al.: A pilot study utilizing intraoperative lymphoscintigraphy for identification of the sentinel lymph nodes in vulvar cancer. Gynecol. Oncol. 66(3), 425-428 (1997).
35. Hampl M, Hantschmann P, Michels W et al.: Validation of the accuracy of the sentinel lymph node procedure in patients with vulvar cancer: results of a multicenter study in Germany. Gynecol. Oncol. 111(2), 282-288 (2008).
36. Johann S, Klaeser B, Krause T et al.: Comparison of outcome and recurrence-free survival after sentinel lymph node biopsy and lymphadenectomy in vulvar cancer. Gynecol. Oncol. 110(3), 324-328 (2008).
37. Louis-Sylvestre C, Evangelista E, Leonard F et al.: Sentinel node localization should be interpreted with caution in midline vulvar cancer. Gynecol. Oncol. 97(1), 151-154 (2005).
38. Martinez-Palones JM, Perez-Benavente MA, Gil-Moreno A et al.: Comparison of recurrence after vulvectomy and lymphadenectomy with and without sentinel node biopsy in early stage vulvar cancer. Gynecol. Oncol. 103(3), 865-870 (2006).
39. Moore RG, Granai CO, Gajewski W et al.: Pathologic evaluation of inguinal sentinel lymph nodes in vulvar cancer patients: a comparison of immunohistochemical staining versus ultrastaging with hematoxylin and eosin staining. Gynecol. Oncol. 91(2), 378-382 (2003).
40. Puig-Tintore LM, Ordi J, Vidal-Sicart S et al.: Further data on the usefulness of sentinel lymph node identification and ultrastaging in vulvar squamous cell carcinoma. Gynecol. Oncol. 88(1), 29-34 (2003).
41. Sliutz G, Reinthaller A, Lantzsch T et al.: Lymphatic mapping of sentinel nodes in early vulvar cancer. Gynecol. Oncol. 84(3), 449-452 (2002).
42. Vidal-Sicart S, Puig-Tintore LM, Lejarcegui JA et al.: Validation and application of the sentinel lymph node concept in malignant vulvar tumours. Eur. J. Nucl. Med. Mol. Imaging 34(3), 384-391 (2007).
43. Van Diest PJ, Torrenga H, Borgstein PJ et al.: Reliability of intraoperative frozen section and imprint cytological investigation of sentinel lymph nodes in breast cancer. Histopathology 35(1), 14-18 (1999).
44. Terada KY, Shimizu DM, Wong JH: Sentinel node dissection and ultrastaging in squamous cell cancer of the vulva. Gynecol. Oncol. 76(1), 40-44 (2000).
45. Hakam A, Nasir A, Raghuwanshi R et al.: Value of multilevel sectioning for improved detection of micrometastases in sentinel lymph nodes in invasive squamous cell carcinoma of the vulva. Anticancer Res. 24(2C), 1281-1286 (2004).
46. Robison K, Steinhoff MM, Granai CO et al.: Inguinal sentinel node dissection versus standard inguinal node dissection in patients with vulvar cancer: a comparison of the size of metastasis detected in inguinal lymph nodes. Gynecol. Oncol. 101(1), 24-27 (2006).
47. Le T, Elsugi R, Hopkins L et al.: The definition of optimal inguinal femoral nodal dissection in the management of vulva squamous cell carcinoma. Ann. Surg. Oncol. 14(7), 2128-2132 (2007).
48. Ansink AC, Sie-Go DM, van der Velden J et al.: Identification of sentinel lymph nodes in vulvar carcinoma patients with the aid of a patent blue V injection: a multicenter study. Cancer 86(4), 652-656 (1999).
49. Terada KY, Shimizu DM, Jiang CS et al.: Outcomes for patients with T1 squamous cell cancer of the vulva undergoing sentinel node biopsy. Gynecol. Oncol. 102(2), 200-203 (2006).
50. Moore RG, Robison K, Brown AK et al.: Isolated sentinel lymph node dissection with conservative management in patients with squamous cell carcinoma of the vulva: a prospective trial. Gynecol. Oncol. 109(1), 65-70 (2008).
51. Merisio C, Berretta R, Gualdi M et al.: Radioguided sentinel lymph node detection in vulvar cancer. Int. J. Gynecol. Cancer 15(3), 493-497 (2005).
52. De Cicco C, Sideri M, Bartolomei M et al.: Sentinel node biopsy in early vulvar cancer. Br. J. Cancer 82(2), 295-299 (2000).
53. Bowles J, Terada KY, Coel MN et al.: Preoperative lymphoscintigraphy in the evaluation of squamous cell cancer of the vulva. Clin. Nucl. Med. 24(4), 235-238 (1999).
54. Echt ML, Finan MA, Hoffman MS et al.: Detection of sentinel lymph nodes with lymphazurin in cervical, uterine, and vulvar malignancies. South. Med. J. 92(2), 204-208 (1999).